Try our business solution for free!

Novartis' spending on research and development by segment 2017-2022

Published by
Matej Mikulic,
Feb 2, 2023
This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2022, by business segment. In 2022, the company spent the highest amount within the given period, around 9.2 billion U.S. dollars, for research and development in the Innovative Medicines division.

Novartis AG's spending on research and development by segment from 2017 to 2022 (in billion U.S. dollars)

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2023

Region

Worldwide

Survey time period

2017 to 2022

Supplementary notes

All figures are rounded.
* During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's R&D expenses are not included from this year onwards.

Open this statistic in...
French
Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical market worldwide "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical market worldwide

Overview

7

Segments

8

Companies

8

R&D, patents, new products

8

Outlook

7

Focus: COVID-19 response

7

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

NovartisGlobal pharmaceutical industryPharmaceutical industry in the U.S.Pfizer
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu